CX Institutional’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $250K | Sell |
2,869
-894
| -24% | -$77.9K | 0.01% | 556 |
|
|
2025
Q1 | $257K | Sell |
3,763
-140
| -4% | -$9.56K | 0.01% | 518 |
|
|
2024
Q4 | $304K | Buy |
3,903
+3,380
| +646% | +$263K | 0.01% | 439 |
|
|
2024
Q3 | $35.1K | Sell |
523
-1,819
| -78% | -$122K | ﹤0.01% | 551 |
|
|
2024
Q2 | $266K | Sell |
2,342
-75
| -3% | -$8.5K | 0.01% | 484 |
|
|
2024
Q1 | $335K | Buy |
2,417
+112
| +5% | +$15.5K | 0.02% | 429 |
|
|
2023
Q4 | $286K | Buy |
+2,305
| New | +$286K | 0.02% | 417 |
|
|
2023
Q3 | – | Sell |
-2,271
| Closed | -$292K | – | 493 |
|
|
2023
Q2 | $292K | Buy |
2,271
+100
| +5% | +$12.9K | 0.02% | 434 |
|
|
2023
Q1 | $251K | Buy |
+2,171
| New | +$251K | 0.01% | 437 |
|
|
2022
Q3 | – | Sell |
-37
| Closed | -$3K | – | 641 |
|
|
2022
Q2 | $3K | Buy |
+37
| New | +$3K | ﹤0.01% | 1063 |
|
|
2021
Q4 | – | Sell |
-356
| Closed | -$49K | – | 485 |
|
|
2021
Q3 | $49K | Buy |
356
+80
| +29% | +$11K | ﹤0.01% | 581 |
|
|
2021
Q2 | $29K | Buy |
276
+168
| +156% | +$17.7K | ﹤0.01% | 665 |
|
|
2021
Q1 | $10K | Buy |
108
+8
| +8% | +$741 | ﹤0.01% | 761 |
|
|
2020
Q4 | $9K | Buy |
100
+92
| +1,150% | +$8.28K | ﹤0.01% | 733 |
|
|
2020
Q3 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 838 |
|